HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Meghna Jani Selected Research
Meghna Jani Research Topics
Disease
12
Rheumatoid Arthritis
01/2021 - 09/2011
6
Necrosis
01/2021 - 02/2015
3
Infections
10/2022 - 01/2019
3
Neoplasms (Cancer)
11/2021 - 01/2019
3
Psoriatic Arthritis
01/2020 - 07/2015
2
Musculoskeletal Diseases (Musculoskeletal Disease)
05/2022 - 11/2018
2
Cancer Pain
11/2021 - 10/2020
2
Psoriasis (Pustulosis Palmaris et Plantaris)
06/2019 - 02/2014
2
Vasculitis (Vasculitides)
11/2018 - 01/2017
2
Weight Gain
02/2018 - 01/2018
2
Sleep Initiation and Maintenance Disorders (Insomnia)
02/2018 - 01/2018
1
Stroke (Strokes)
10/2022
1
Leukopenia
10/2022
1
Myocardial Infarction
10/2022
1
Pancytopenia
10/2022
1
Colorectal Neoplasms (Colorectal Cancer)
10/2022
1
Hypertension (High Blood Pressure)
01/2021
1
Fibromyalgia (Fibrositis)
10/2020
1
Substance-Related Disorders (Drug Abuse)
10/2020
1
Alcoholism (Alcohol Abuse)
10/2020
1
Synovitis
10/2020
1
Drug-Related Side Effects and Adverse Reactions
02/2018
1
Coinfection
12/2017
1
Pneumonia (Pneumonitis)
12/2017
1
Rheumatic Diseases (Rheumatism)
05/2015
1
Interstitial Lung Diseases (Interstitial Lung Disease)
05/2014
1
Joint Diseases (Joint Disease)
05/2014
1
Crohn Disease (Crohn's Disease)
02/2014
1
Cryptococcal Meningitis
09/2011
1
Asthma (Bronchial Asthma)
10/2005
Drug/Important Bio-Agent (IBA)
13
Pharmaceutical Preparations
IBA
05/2022 - 02/2014
9
Biological Products
IBA
05/2022 - 02/2014
8
Antibodies
IBA
01/2021 - 02/2014
5
Antirheumatic Agents (DMARD)
IBA
01/2021 - 07/2015
4
Etanercept (Enbrel)
FDA Link
01/2021 - 05/2015
4
Glucocorticoids
IBA
01/2021 - 06/2017
4
Adalimumab (Humira)
FDA Link
01/2021 - 05/2015
3
Opioid Analgesics (Opioids)
IBA
11/2021 - 01/2019
3
Certolizumab Pegol
FDA Link
01/2021 - 01/2017
3
Tumor Necrosis Factor Inhibitors
IBA
01/2020 - 06/2017
2
golimumab
FDA Link
01/2021 - 06/2017
2
Infliximab (Remicade)
FDA Link
01/2021 - 06/2017
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2021 - 05/2015
2
tocilizumab (atlizumab)
FDA Link
01/2019 - 06/2017
2
Steroids
IBA
01/2019 - 10/2005
2
Abatacept (Orencia)
FDA Link
06/2017 - 03/2012
2
Rituximab (Mabthera)
FDA Link
06/2017 - 09/2011
2
Methotrexate (Mexate)
FDA Link
Generic
06/2017 - 02/2014
1
Immunosorbents
IBA
01/2021
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2021
1
A 17 (A-17)
IBA
01/2021
1
Enzymes
IBA
01/2021
1
C-Reactive Protein
IBA
10/2020
1
MME
IBA
10/2020
1
Pharmacological Biomarkers
IBA
01/2020
1
Interferons
IBA
06/2019
1
Janus Kinase Inhibitors
IBA
06/2017
1
sarilumab
IBA
06/2017
1
Biosimilar Pharmaceuticals
IBA
06/2017
1
tofacitinib
IBA
06/2017
1
Sulfasalazine (Azulfidine)
FDA Link
Generic
06/2017
1
sirukumab
IBA
06/2017
1
clazakizumab
IBA
06/2017
1
baricitinib
IBA
06/2017
1
Leflunomide (Arava)
FDA Link
Generic
06/2017
1
Janus Kinases
IBA
06/2017
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
07/2015
Therapy/Procedure
4
Therapeutics
11/2018 - 12/2017
3
Biological Therapy
06/2019 - 05/2014
1
Aftercare (After-Treatment)
10/2022
1
Precision Medicine
07/2015